Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth J Baum

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Clinical Cardiology|June 30, 2019
Rounding the corner on residual risk: Implications of REDUCE-IT for omega-3 polyunsaturated fatty acids treatment in secondary prevention of atherosclerotic cardiovascular diseaseSeth J Baum, Kenneth P Scholz
Cardiovascular Endocrinology|October 25, 2019
A review of the evidence for alternative and complementary medical approaches in the prevention of atherosclerotic cardiovascular disease and diabetesJonathan P Nieves, Seth J Baum
Reviews in Cardiovascular Medicine|September 13, 2018
Familial Hypercholesterolemia: Although Identification Advances, Appreciation and Treatment LagSeth J Baum, Alan S Brown
Clinical Cardiology|March 8, 2018
PCSK9 inhibitor valuation: A science-based review of the two recent modelsSeth J Baum, Christopher P Cannon
Reviews in Cardiovascular Medicine|September 27, 2016
Emerging Treatments for Heterozygous and Homozygous Familial HypercholesterolemiaSeth J Baum, Daniel Soffer, P Barton Duell
JAMA|November 28, 2023
USPSTF Recommendation on Screening for Lipid Disorders in Children and AdolescentsKatherine Wilemon, Joshua W Knowles, Seth J Baum
Cardiology Clinics|May 6, 2015
Statins and diabetesKevin C Maki, Mary R Dicklin, Seth J Baum
Reviews in Cardiovascular Medicine|September 13, 2018
Access to PCSK9 InhibitorsSeth J Baum, Norman E Lepor, Jennifer G Robinson
Clinical Cardiology|October 27, 2016
The American Society for Preventive Cardiology: Our 30-year legacyNathan D Wong, Laurence S Sperling, Seth J Baum
Endocrinology and Metabolism Clinics of North America|February 20, 2016
Statins and DiabetesKevin C Maki, Mary R Dicklin, Seth J Baum
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Clinical Cardiology|June 30, 2019
Rounding the corner on residual risk: Implications of REDUCE-IT for omega-3 polyunsaturated fatty acids treatment in secondary prevention of atherosclerotic cardiovascular diseaseSeth J Baum, Kenneth P Scholz
Cardiovascular Endocrinology|October 25, 2019
A review of the evidence for alternative and complementary medical approaches in the prevention of atherosclerotic cardiovascular disease and diabetesJonathan P Nieves, Seth J Baum
Reviews in Cardiovascular Medicine|September 13, 2018
Familial Hypercholesterolemia: Although Identification Advances, Appreciation and Treatment LagSeth J Baum, Alan S Brown
Clinical Cardiology|March 8, 2018
PCSK9 inhibitor valuation: A science-based review of the two recent modelsSeth J Baum, Christopher P Cannon
Reviews in Cardiovascular Medicine|September 27, 2016
Emerging Treatments for Heterozygous and Homozygous Familial HypercholesterolemiaSeth J Baum, Daniel Soffer, P Barton Duell
JAMA|November 28, 2023
USPSTF Recommendation on Screening for Lipid Disorders in Children and AdolescentsKatherine Wilemon, Joshua W Knowles, Seth J Baum
Cardiology Clinics|May 6, 2015
Statins and diabetesKevin C Maki, Mary R Dicklin, Seth J Baum
Reviews in Cardiovascular Medicine|September 13, 2018
Access to PCSK9 InhibitorsSeth J Baum, Norman E Lepor, Jennifer G Robinson
Clinical Cardiology|October 27, 2016
The American Society for Preventive Cardiology: Our 30-year legacyNathan D Wong, Laurence S Sperling, Seth J Baum
Endocrinology and Metabolism Clinics of North America|February 20, 2016
Statins and DiabetesKevin C Maki, Mary R Dicklin, Seth J Baum
Pageof 9